Outcomes of a preoperative risk-based transfusion assignment protocol in sickle cell disease patients: a single-center retrospective study from Saudi Arabia

References

• Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31(3):289–293. doi:10.4103/0256-4947.81540.
   PubMed Web of Science ®Google Scholar
• Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol. 2005;79(1):17–25. doi:10.1002/ajh.20336.
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294. doi:10.1182/blood.V91.1.288
   PubMed Web of Science ®Google Scholar
• Ramakrishnan M, Moïsi JC, Klugman KP, et al. Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):329–337. doi:10.1016/S1473-3099(10)70055-4.
   PubMed Web of Science ®Google Scholar
• Adam S, Jonassaint J, Kruger H, et al. Surgical and obstetric outcomes in adults with sickle cell disease. Am J Med. 2008;121(10):916–921. doi:10.1016/j.amjmed.2008.04.040.
   PubMed Web of Science ®Google Scholar
• Halvorson DJ, McKie V, McKie K, Ashmore PE, Porubsky ES. Sickle cell disease and tonsillectomy: preoperative management and postoperative complications. Arch Otolaryngol - Head Neck Surg. 1997;123(7):689–692. doi:10.1001/archotol.1997.01900070033005.
   PubMedGoogle Scholar
• Buck J, Davies SC. Surgery in sickle cell disease. Hematol Oncol Clin North Am. 2005;19(5):897–902. doi:10.1016/j.hoc.2005.07.004.
   PubMed Web of Science ®Google Scholar
• Wanko SO, Telen MJ. Transfusion management in sickle cell disease. Hematol Oncol Clin North Am. 2005;19(5):803–826. doi:10.1016/j.hoc.2005.07.002.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Luban NLC, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001;41(9):1086–1092. doi:10.1046/j.1537-2995.2001.41091086.x.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333(4):206–214. doi:10.1056/NEJM199507273330402.
   PubMed Web of Science ®Google Scholar
• Howard J, Malfroy M, Llewelyn C, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet. 2013;381(9870):930–938. doi:10.1016/S0140-6736(12)61726-7.
   PubMed Web of Science ®Google Scholar
• Al-Jaouni SK, Al-Muhayawi SM, Qari MH, Nawas MA, Al-Mazrooa A. Randomized clinical trial to evaluate the safety of avoiding pre-operative transfusion in sickle cell anemia. Bahrain Med Bull. 2006;28(4):164–167.
   Google Scholar
• Alotaibi GS, Alsaleh K, Bolster L, McMurtry MS, Wu C. Preoperative transfusion in patients with sickle cell disease to prevent perioperative complications: a systematic review and meta-analysis. Hematology. 2014;19(8):463–471. doi:10.1179/1607845414Y.0000000158.
   PubMed Web of Science ®Google Scholar
• Alsultan A, Aleem A, Ghabbour H, et al. Sickle cell disease subphenotypes in patients from Southwestern Province of Saudi Arabia. J Pediatr Hematol Oncol. 2012;34(2):79–84. doi:10.1097/MPH.0b013e3182422844.
   PubMed Web of Science ®Google Scholar
• Schnog JJB, Lard LR, Rojer RA, Van Der Dijs FPL, Muskiet FAJ, Duits AJ. New concepts in assessing sickle cell disease severity. Am J Hematol. 1998;58(1):61–66. doi:10.1002/(SICI)1096-8652(199805)58:1 < 61::AID-AJH11 > 3.0.CO;2-8.
   PubMed Web of Science ®Google Scholar
• Quinn CT. Minireview: clinical severity in sickle cell disease: the challenges of definition and prognostication. Exp Biol Med (Maywood)). 2016;241(7):679–688. doi:10.1177/1535370216640385.
   PubMed Web of Science ®Google Scholar
• van den Tweel XW, van der Lee JH, Howard J, Fijnvandraat K, Van Oers M. Measurement of disease severity in patients with sickle cell disease_ a systematic review. Blood. 2007;110(11):2250–2250. doi:10.1182/blood.V110.11.2250.2250.
   PubMed Web of Science ®Google Scholar
• Jain S, Bakshi N, Krishnamurti L. Acute chest syndrome in children with sickle cell disease. Pediatr Allergy Immunol Pulmonol. 2017;30(4):191–201. doi:10.1089/ped.2017.0814.
   PubMed Web of Science ®Google Scholar
• Paul RN, Castro OL, Aggarwal A, Oneal PA. Acute chest syndrome: sickle cell disease. Eur J Haematol. 2011;87(3):191–207. doi:10.1111/j.1600-0609.2011.01647.x.
   PubMed Web of Science ®Google Scholar
• Vichinsky EP, Neumayr LD, Haberkern C, et al. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the national sickle cell surgery study group. Am J Hematol. 1999;62(3):129–138. doi:10.1002/(SICI)1096-8652(199911)62:3 < 129::AID-AJH1 > 3.0.CO;2-J.
   PubMed Web of Science ®Google Scholar
• Koshy M, Weiner SJ, Miller ST, et al. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood. 1995;86(10):3676–3684. doi:10.1182/blood.V86.10.3676.bloodjournal86103676
   PubMed Web of Science ®Google Scholar
• Adjepong KO, Otegbeye F, Adjepong YA. Perioperative management of sickle cell disease. Mediterr J Hematol Infect Dis. 2018;10(1):2018032. doi:10.4084/mjhid.2018.032.
   Google Scholar
• Mandal S, Westra J, Apushkin M, et al. Automated red cell exchange: a simplified formula for how many red cell units to exchange and validity of haemoglobin S levels measured one to two hours later. Blood Transfus. 2014;12(Suppl.1):s145–s146. doi:10.2450/2013.0267-12.
   PubMedGoogle Scholar
• Fun Yi L, Wong R, Chan NPH, et al. Provision of phenotype-matched blood units: no need for pre-transfusion antibody screening. Haematologica. 2001;86(7):742–748.
   PubMed Web of Science ®Google Scholar
• Kutner J, Mota M, Conti F, Castilho L. Blood genotyping for improved outcomes in chronic transfusion patients: current and future perspectives. Int J Clin Transfus Med. 2014:65–72. doi:10.2147/ijctm.s48394.
   Google Scholar
• Haberkern CM, Neumayr LD, Orringer EP, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the national preoperative transfusion study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997;89(5):1533–1542. doi:10.1182/blood.V89.5.1533
   PubMed Web of Science ®Google Scholar
• Wali YA, Al Okbi H, Al Abri R. A comparison of two transfusion regimens in the perioperative management of children with sickle cell disease undergoing adenotonsillectomy. Pediatr Hematol Oncol. 2003;20(1):7–13. doi:10.1080/0880010390158487.
   PubMed Web of Science ®Google Scholar
• Schyrr F, Dolci M, Nydegger M, et al. Perioperative care of children with sickle cell disease: a systematic review and clinical recommendations. Am J Hematol. 2020;95(1):78–96. doi:10.1002/ajh.25626.
   PubMedGoogle Scholar
• Akinsheye I, Alsultan A, Solovieff N, et al. Fetal hemoglobin in sickle cell anemia. Blood. 2011;118(1):19–27. doi:10.1182/blood-2011-03-325258.
   PubMed Web of Science ®Google Scholar
• Mpalampa L, Ndugwa CM, Ddungu H, Idro R. Foetal haemoglobin and disease severity in sickle cell anaemia patients in Kampala, Uganda. BMC Blood Disord. 2012;12:1–7. doi:10.1186/1471-2326-12-11.
   PubMedGoogle Scholar
• Chou ST, Alsawas M, Fasano RM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020;4(2):327–355. doi:10.1182/bloodadvances.2019001143.
   PubMed Web of Science ®Google Scholar